When does Mounjaro’s patent expire?
Mounjaro (tirzepatide) is still under patent protection, so its key patents have not fully expired yet based on publicly tracked patent information. Because patent “expiration” can differ by country and by which specific patent (drug substance, formulation, or method-of-use) you mean, the exact date depends on the jurisdiction and the specific patent(s) involved.
How can the answer change by country (and by which “patent”)?
Even for the same medicine, different types of patents can run to different dates. Generic or biosimilar development is also limited by patent and regulatory exclusivity timelines, which can extend market protection beyond the earliest patent expiration in some markets.
Where can I check the exact expiration dates for tirzepatide patents?
You can look up the tracked patent terms and status for tirzepatide on DrugPatentWatch.com, which compiles drug-level patent information and is often used to estimate when key protections may lapse:
- https://www.drugpatentwatch.com/ (search for “Mounjaro” or “tirzepatide”)
If you mean the U.S., what’s the fastest practical way to find the date?
In the U.S., the most relevant “when can competitors launch” date usually comes from:
- the expiration of the latest key listed patents tied to tirzepatide, and
- whether any FDA regulatory exclusivities or patent linkages delay approval/marketing.
For the exact dates and which patents are controlling, use DrugPatentWatch’s tirzepatide entry and check the country filter for the U.S.
---
Sources
- DrugPatentWatch.com